Mark E. Johnson
Impact in
- Pharmaceutical Science top 0.5%
- Advancements in Transdermal Drug Delivery
- Dermatology top 2%
- Dermatology and Skin Diseases
- Contact Dermatitis and Allergies
Papers in
-
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 5
-
- Immunotherapy and Immune Responses 4
- Co-authors
- Daniel Blankschtein (4 shared papers)Jan Nouta (1 shared paper)Rienk Offringa (1 shared paper)Grayson B. Lipford (1 shared paper)Sjoerd H. van der Burg (1 shared paper)Cornelis J.M. Melief (1 shared paper)Samir Mitragotri (2 shared papers)Zhibin Guan (6 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (3 papers)Biophysical Journal (2 papers)Cancer (2 papers)Life Sciences (2 papers)Beilstein Journal of Organic Chemistry (1 paper)
- Partner nations
- United StatesSpainGermany
In The Last Decade
Mark E. Johnson
32 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 125
- Pharmaceutical Science 427
- Dermatology 197
- Immunology 356
- Hepatology 98
- Molecular Biology 684
Countries citing papers authored by Mark E. Johnson
This map shows the geographic impact of Mark E. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Johnson more than expected).
Fields of papers citing papers by Mark E. Johnson
This network shows the impact of papers produced by Mark E. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Johnson. The network helps show where Mark E. Johnson may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Johnson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 365 | |
| 2 | 1997 | 278 | |
| 3 | 2003 | 124 | |
| 4 | 2005 | 117 | |
| 5 | 1996 | 114 | |
| 6 | 1993 | 108 | |
| 7 | 2002 | 93 | |
| 8 | 1995 | 88 | |
| 9 | 1999 | 73 | |
| 10 | 2015 | 61 | |
| 11 | 2016 | 45 | |
| 12 | 1998 | 44 | |
| 13 | 1985 | 41 | |
| 14 | 2006 | 40 | |
| 15 | 2000 | 35 | |
| 16 | 2006 | 28 | |
| 17 | 2018 | 28 | |
| 18 | 1986 | 24 | |
| 19 | 1997 | 23 | |
| 20 | 1999 | 22 |
About Mark E. Johnson
Mark E. Johnson is a scholar working on Molecular Biology, Immunology, Surgery, Pulmonary and Respiratory Medicine and Rheumatology, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Bone Tumor Diagnosis and Treatments (4 papers), Dendrimers and Hyperbranched Polymers (4 papers), Immunotherapy and Immune Responses (4 papers), Liver physiology and pathology (3 papers), Dermatology and Skin Diseases (3 papers) and Advancements in Transdermal Drug Delivery (3 papers). The work is most often cited by research in Pharmaceutical Science (427 citations), Dermatology (197 citations), Immunology (356 citations), Hepatology (98 citations) and Molecular Biology (684 citations). Mark E. Johnson has collaborated with scholars based in United States, Spain and Germany. Frequent co-authors include Daniel Blankschtein, Jan Nouta, Rienk Offringa, Grayson B. Lipford, Sjoerd H. van der Burg, Cornelis J.M. Melief, Samir Mitragotri, Zhibin Guan, George Koukoulis and Anand Iyer. Their work appears in journals such as Journal of Pharmaceutical Sciences, Biophysical Journal, Cancer, Life Sciences and Beilstein Journal of Organic Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.